| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 191,247 | 111,214 | 143,385 | 115,591 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 191,247 | 111,214 | 143,385 | 115,591 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 101,961 | 99,450 | 112,124 | 106,685 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 45,231 | (33,528) | 33,528 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 44,055 | 45,292 | (2,267) | 8,906 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 45,175 | 48,016 | (869) | 7,333 | | Interest Expense | 1,512 | 1,513 | 1,512 | 1,513 | | Income Before Tax | 43,663 | 46,503 | (2,381) | 5,820 | | Income Tax Expense | 12,644 | 12,423 | (565) | (161) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 31,019 | 34,080 | (1,816) | 5,981 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 31,019 | 34,080 | (1,816) | 5,981 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $31,019 | $34,080 | ($1,816) | $5,981 |
|
0.51% Nasdaq 
Income Statement
